Ospedale Santa Croce-Carle Cuneo

Quick facts

Phase 2 pipeline

• CONVENTIONAL ABVD · Oncology
  This chemotherapy regimen combines Adriamycin, Bleomycin, Vinblastine, and Dacarbazine to target rapidly dividing cancer cells.
• ESCALATED BEACOPP · Oncology
  Beacopan is a monoclonal antibody that targets CD137, a member of the tumor necrosis factor receptor superfamily.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Ospedale Santa Croce-Carle Cuneo portfolio CI brief
• Ospedale Santa Croce-Carle Cuneo pipeline updates RSS